Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001641172-25-001350
Filing Date
2025-03-31
Accepted
2025-03-31 06:00:18
Documents
2

Document Format Files

Seq Description Document Type Size
1 form424b5.htm 424B5 473614
2 form424b5_001.jpg GRAPHIC 12836
  Complete submission text file 0001641172-25-001350.txt   492583
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filer) CIK: 0001855485 (see all company filings)

EIN.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-284229 | Film No.: 25788548
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)